Therapeutic Development
Media
GSK Makes Strategic $1.15 Billion Move to Acquire IDRx, Strengthening Its Cancer Treatment Portfolio
British pharmaceutical giant GSK has announced its agreement to acquire Boston-based biotechnology firm IDRx for up to $1.15 billion, marking a significant expansion...
Billionairesworld's billionaires
Feng Yuxia: Steering Joinn Laboratories Toward Global Leadership in Medical Services
In the ever-evolving landscape of global healthcare, few figures have made as indelible a mark as Feng Yuxia, the visionary chair of Joinn...
